BIOA vs TECH · rev $2.1M vs P/E 65, rev $1.22B
BioAge Labs, Inc (BIOA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BIOA revenue for 2025-09-30 was $2.1M. Net income was -$54.7M. Revenue was down 14.8% from 2025-06-30 to 2025-09-30. BIOA currently screens at market cap $697.9M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BIOA currently screens at market cap $697.9M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BIOA and TECH stock pages for the full models.
Not investment advice.